LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
IDXGCIK 0001054102

INTERPACE BIOSCIENCES, INC.

17 transactions by 8 insiders, from January 20, 2026 to August 20, 2026.

Transactions
178 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
Nonenobody sold on the open market
Net
+$0net buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Thomas W. BurnellCEO5———
Christopher McCarthyCFO4———
Joseph D. KeeganDir1———
Fortunato R. RoccaDir1———
Stephen J. SullivanDir1———
Vijay AggarwalDir1———

Large holders and funds

Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.

InsiderTradesPlannedBoughtSold
1315 Capital II, L.P.10%2———
Ampersand 2018 Limited Partnership10%2———

All transactions

17 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Fortunato R. RoccaDirDERIVAug 20A69,252$0.00—?
Joseph D. KeeganDirDERIVAug 20A69,252$0.00—?
Stephen J. SullivanDirDERIVAug 20A69,252$0.00—?
Christopher McCarthyCFODERIVAug 20A277,009$0.00—?
Christopher McCarthyCFODERIVAug 20M277,009$0.00—?
Christopher McCarthyCFODERIVAug 20A554,018$0.00—?
Christopher McCarthyCFOAug 20M277,009$0.00—
Thomas W. BurnellCEODERIVAug 20A554,018$0.00—?
Thomas W. BurnellCEODERIVAug 20M1,966,763$0.00—?
Thomas W. BurnellCEODERIVAug 20A1,966,763$0.00—?
Thomas W. BurnellCEOAug 20F581,718$1.61$937K
Thomas W. BurnellCEOAug 20M1,966,763$0.00—
Vijay AggarwalDirDERIVAug 20A69,252$0.00—?
1315 Capital II, L.P.10%DERIVJan 20C19,000$0.00—?
1315 Capital II, L.P.10%Jan 20C9,405,941$2.02$19.0M
Ampersand 2018 Limited Partnership10%DERIVJan 20C28,000$0.00—?
Ampersand 2018 Limited Partnership10%Jan 20C13,861,386$2.02$28.0M